Galletti F, Strazzullo P, Cappuccio F P, Barba G, Giorgione N, Gagliardi R, Mancini M
Institute of Internal Medicine and Metabolic Disease, II Medical School, University of Naples, Italy.
Cardiovasc Drugs Ther. 1989 Apr;3(2):135-40. doi: 10.1007/BF01883856.
Thirteen patients with mild to moderate essential hypertension and whose average supine blood pressure with no treatment was 165/104 mmHg were studied as inpatients for 3 consecutive one-week periods on different sodium intakes. On the last day of each dietary period, they received a single, 20-mg nitrendipine tablet and blood pressure was monitored every 10 minutes for 2 hours after drug administration. Nitrendipine significantly lowered blood pressure independently of the level of sodium intake, and the maximum blood-pressure lowering effect was achieved approximately 1 hour after the dose. The blood-pressure lowering effect of nitrendipine was greater on high sodium intake as compared to low sodium intake (p less than 0.02), and it was also greater with higher initial blood pressures. However, the sodium-related effect on blood pressure was, at least in part, independent of the pretreatment blood pressure. These results suggest that calcium antagonists, such as nitrendipine, are effective in reducing blood pressure in patients with essential hypertension and could be drugs of choice in those who are unable to restrict their salt intake.
13例轻度至中度原发性高血压患者,其未经治疗时的平均仰卧血压为165/104 mmHg,作为住院患者在连续3个为期1周的不同钠摄入量阶段进行了研究。在每个饮食阶段的最后一天,他们服用一片20毫克的尼群地平片,并在给药后2小时内每10分钟监测一次血压。尼群地平可独立于钠摄入水平显著降低血压,最大降压效果在给药后约1小时达到。与低钠摄入相比,高钠摄入时尼群地平的降压效果更大(p小于0.02),且初始血压越高效果也越大。然而,钠对血压的影响至少部分独立于治疗前血压。这些结果表明,钙拮抗剂如尼群地平对降低原发性高血压患者的血压有效,对于那些无法限制盐摄入的患者可能是首选药物。